Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ACRSACRS
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ACLARIS THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 3.2M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $16.9M as of 2026-Q2. The position was increased (+31.6% shares). ACRS represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$16.9M

Current Shares

3.2M

Total Value Change

+$15.9M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.2M
+31.6%
$16.9M0.0%$5.29
36
2026-Q1
Increased
2.4M
+1.3%
$9.1M0.0%$3.75
28
2025-Q4
Increased
2.4M
+0.1%
$7.2M0.0%$3.01
27
2025-Q3
Decreased
2.4M
-3.0%
$4.5M0.0%$1.90
0
2025-Q2
Increased
2.5M
+108.4%
$3.5M0.0%$1.42
43
2025-Q1
Increased
1.2M
+49.8%
$1.8M0.0%$1.53
36
2024-Q4
Decreased
789,597
-6.7%
$2M0.0%$2.48
0
2024-Q3
Increased
846,446
+9.3%
$973,5770.0%$1.15
27

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used